[x] Close ad

TRANYLCYPROMINE

Tranylcypromine chemical structure
Tranylcypromine
Systematic (IUPAC) name
2-phenylcyclopropan-1-amine
Identifiers
CAS number 155-09-9
ATC code N06AF04
PubChem 5530
DrugBank APRD00645
Chemical data
Formula C9H11N
Mol. weight 133.19
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half life 4.4 - 8 hours
Excretion Urine
Feces
Therapeutic considerations
Pregnancy cat.

C (United States

Legal status

Unscheduled

Routes Oral

Tranylcypromine (sold under the brand name Parnate®) is a monoamine oxidase inhibitor (MAOI) used as an antidepressant drug.

Contents

Pharmacology

Tranylcypromine is a non-hydrazine, irreversible monoamine oxidase inhibitor, and has a rapid onset of action.

The antidepressant activity of tranylcypromine is thought to be due to the fact that it increases the concentration of epinephrine, norepinephrine, and serotonin throughout the nervous system. This is achieved through the inhibition of monoamine oxidase.

Indications

Tranylcypromine is used for the treatment of major depressive episodes, without melancholia. The major usage for Tranylcypromine today is in the treatment of treatment-resistant depression.

Contraindications

As with other MAOIs, those who are taking tranylcypromine must adhere to rigid dietary specifications in order to prevent complications.

Overdose

Symptoms of tranylcypromine overdose may include: insomnia, restlessness, anxiety, agitation, mental confusion, hypotension, dizziness, weakness, somnolence, hypertension, and headache.

Dietary restrictions

Foods high in tyramine can precipitate hypertensive crisis. Tyramine can be found in cheeses, wine, and certain meats. MAOIs inhibit tyramine breakdown, thus dietary intake should be avoided. See a complete List of foods containing tyramine.

External links


Antidepressants (ATC N06A) edit
Monoamine oxidase inhibitors (MAOI) Harmaline, Iproclozide, Iproniazid, Isocarboxazid, Nialamide, Phenelzine, Selegiline, Toloxatone, Tranylcypromine
Reversible inhibitor of monoamine oxidase A (RIMA) Brofaromine, Moclobemide
Dopamine reuptake inhibitor (DARI) Amineptine, Methylphenidate, Nomifensine, Phenmetrazine, Vanoxerine
Norepinephrine-dopamine reuptake inhibitors Bupropion
Norepinephrine reuptake inhibitor (NRI) or (NARI) Atomoxetine, Maprotiline, Reboxetine, Viloxazine
Serotonin-norepinephrine reuptake inhibitor (SNRI) Desipramine, Duloxetine, Milnacipran, Venlafaxine
Selective serotonin reuptake inhibitor (SSRI) Alaproclate, Etoperidone, Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Zimelidine
Selective serotonin reuptake enhancer (SSRE) Tianeptine
Tricyclic antidepressants (TCA) Amitriptyline, Amoxapine, Butriptyline, Clomipramine, Desipramine, Dibenzepin, Dothiepin, Doxepin, Imipramine, Iprindole, Lofepramine, Melitracen, Nortriptyline, Opipramol, Protriptyline, Trimipramine
Tetracyclic antidepressants Maprotiline, Mianserin, Nefazodone, Trazodone
Noradrenergic and specific serotonergic antidepressant (NaSSA) Mirtazapine